 |
Julia Karow tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Julia Karow or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Ariosa Enrolling for Trial Comparing NGS-Based T21 Test to Standard First-Trimester Prenatal Screening
December 19, 2012
Ariosa Enrolling for Trial Comparing NGS-Based T21 Test to Standard First-Trimester Prenatal Screening
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- MaterniT21 Doubles Sequenom's Revenues; Firm Inks Deal with Blue Cross Blue Shield Association
May 15, 2013 / Clinical Sequencing News - NIPT Developers Consider Sub-Chromosomal Alterations
May 1, 2013 / Clinical Sequencing News - USPTO Grants Ariosa Request to Review Key Sequenom Patent
April 3, 2013 / Clinical Sequencing News - GenomeWeb Feature: Prenatal Testing, Carrier Screening Emerge as Early Markets for Widespread Sequencing
March 13, 2013 / Clinical Sequencing News - Facing Increased Competition, Sequenom Sees Continued Growth of MaterniT21 Test in Q4 2012
March 13, 2013 / Clinical Sequencing News